Search results for "Algorithm"

showing 10 items of 4887 documents

Selection Correction in Panel Data Models: An Application to Labour Supply and Wages

2000

In recent years a number of panel estimators have been suggested for sample selection models, where both the selection equation and the equation of interest contain individual effects which are correlated with the explanatory variables. We review and compare some of these estimators, and apply them to estimating the return to actual labour market experience for females, using a panel of twelve years. All these estimators rely on the assumption of strict exogeneity of regressors in the equation of interest, conditional on individual specific effects and the selection mechanism. This assumption is likely to be violated in many applications. Also, life history variables are often measured with…

Observational errorLabour supplyComponent (UML)StatisticsEconomicsEconometricsSurvey data collectionEstimatorEndogeneitySelection (genetic algorithm)Panel dataSSRN Electronic Journal
researchProduct

The spanning tree based approach for solving the shortest path problem in social graphs

2016

This thesis is devoted to the shortest path problem in social graphs. Social graphs represent individuals and social relationships between them. As for social networking sites, their users are represented as vertices of the social graph, and the relationship which indicates whether two users are friends in the social networking site are represented as edges of the social graph. Therefore, social graphs are widely investigated by sociologists in order to determine rules and properties of various social processes. Analysis of such social graphs may be used in prediction of results of election, or recommendation systems. Calculation of many social graph metrics requires computation of shortest…

Odnoklassnikisocial network analysissosiaaliset verkostotsocial graphalgoritmitsosiaalinen mediathe Atlas algorithmgraafitshortest path problem
researchProduct

Self-Healing of Redundant FLASH ADCs

2022

For the design of high-speed ADCs, the traditional speed-accuracy trade-off can only be solved at the expense of power consumption. Using fast small transistors takes full advantage of technology scaling but induces large amounts of random variability. Redundancy has been proposed as a way to cope with variability in FLASH converter and open the trade-off. The offset of redundant comparators are measured and only the best candidates which have been selected are powered-up. However, the candidate selection is usually carried out in foreground and a lot of silicon area is thus occupied by comparators that will only be used once, during calibration. In this paper we show how such an approach, …

Offset (computer science)ComparatorComputer scienceTransistorlaw.inventionFlash (photography)Hardware and ArchitecturelawSpare partCalibrationElectronic engineeringRedundancy (engineering)Electrical and Electronic EngineeringSoftwareSelection (genetic algorithm)IEEE Design & Test
researchProduct

A fully automated method for accurate measurement of geometrical distortion in magnetic resonance imaging of a 3D-lattice phantom

2019

Abstract This paper describes an automated method for extracting the apparent positions of fiducial points from 2D or 3D images of a phantom. We consider a 3D-lattice phantom for two main reasons: first, ease of manufacture and isotropy of its structure with respect to coordinate projections; second, a connected structure allowing to uniquely assess the adjacency relationship between fiducial points even if geometric distortions arising from main magnet inhomogeneity and gradient fields non-linearity is severe as observed in open-bore systems. In order to validate our proposed method and compare different choices for the parameters of our phantom (i.e. number and distance between grids and …

Offset (computer science)RegistrationImage qualityComputer scienceBiomedical EngineeringBiophysicsImage enhancement/restoration (noise and artifact reduction)Signal-To-Noise RatioImaging phantomPattern Recognition Automated030218 nuclear medicine & medical imaging03 medical and health sciencesImaging Three-Dimensional0302 clinical medicineSoftwareRobustness (computer science)HumansComputer SimulationRadiology Nuclear Medicine and imagingMagnetic resonance imaging (MRI)Fiducial point localizationElectronic Data ProcessingPhantoms ImagingSettore ING-INF/03 - Telecomunicazionibusiness.industryAirSpherical harmonicsModels TheoreticalMagnetic Resonance ImagingPhantom designPersonal computerAdjacency listbusinessAlgorithmSoftware030217 neurology & neurosurgeryMagnetic Resonance Imaging
researchProduct

germline mutations in women with familial breast cancer and a relative with haematological malignancy

2009

Biallelic inactivation of the ATM gene causes ataxia-telangiectasia (A-T), a complex neurological disease associated with a high risk of leukaemias and lymphomas. Mothers of A-T children, obligate ATM heterozygote mutation carriers, have a breast cancer (BC) relative risk of about 3. The frequency of ATM carriers in BC women with a BC family history has been estimated to be 2.70%. To further our clinical understanding of familial BC and examine whether haematological malignancies are predictive of ATM germline mutation, we estimated the frequency of heterozygote mutation carriers in a series of 122 BC women with a family history of both BC and haematological malignancy and without BRCA1/2 m…

OncologyCancer ResearchLymphomaDNA Mutational AnalysisCell Cycle ProteinsAtaxia Telangiectasia Mutated Proteins0302 clinical medicineBreast cancerGene FrequencyRisk FactorsMissense mutationGenetics0303 health scienceseducation.field_of_studyLeukemiafamilial breast cancerAtaxia–telangiectasiaPedigreeDNA-Binding ProteinsOncology030220 oncology & carcinogenesisMutation (genetic algorithm)EMMAFemaleAdultHeterozygotemedicine.medical_specialtyMolecular Sequence DataPopulationBreast NeoplasmsProtein Serine-Threonine KinasesBiologyRisk Assessment03 medical and health sciencesGermline mutationBreast cancerPredictive Value of TestsInternal medicinemedicineHumansGenetic Predisposition to DiseaseGenetic TestingeducationAllele frequencyGerm-Line Mutation030304 developmental biologyBase SequenceTumor Suppressor ProteinsHeterozygote advantagemedicine.diseaseAtaxia-telangiectasia
researchProduct

Phase II Trial of Preoperative Irinotecan–Cisplatin Followed by Concurrent Irinotecan–Cisplatin and Radiotherapy for Resectable Locally Advanced Gast…

2009

Purpose To determine in a Phase II trial whether preoperative irinotecan–cisplatin (IC) followed by concurrent IC therapy and radiotherapy (IC/RT) improved outcome in patients with resectable, locally advanced gastric adenocarcinoma (GC) or esophagogastric junction cancer (EGJC). Patients and Methods Patients with resectable Stage II–IV, M0 GC or EGJC made up the study population. The primary endpoint was pathologic complete response (pCR). Two courses of IC (irinotecan, 65mg/m 2 ; cisplatin, 30mg/m 2 on Days 1 and 8 every 21 days) were given. Patients without progression then received IC/RT, consisting of daily radiotherapy (45Gy) with concurrent IC (irinotecan, 65mg/m 2 ; cisplatin, 30mg/…

OncologyCancer Researchmedicine.medical_specialtyEsophageal Neoplasmsmedicine.medical_treatmentAdenocarcinomaNeutropeniaIrinotecanGastroenterologyDrug Administration ScheduleStomach NeoplasmsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsHumansMedicineRadiology Nuclear Medicine and imagingProspective StudiesProspective cohort studySurvival rateCisplatinChemotherapyRadiationbusiness.industryRemission Inductionmedicine.diseaseCombined Modality TherapySurvival RateRadiation therapyIrinotecanOncologySpainPreoperative PeriodAdenocarcinomaCamptothecinEsophagogastric JunctionCisplatinbusinessAlgorithmsmedicine.drugInternational Journal of Radiation Oncology*Biology*Physics
researchProduct

Serial circulating tumor DNA analysis to assess recurrence risk, benefit of adjuvant therapy, growth rate and early relapse detection in stage III co…

2021

3540 Background: Challenges in the postoperative management of stage III colorectal cancer include: 1) selection of high-risk patients for adjuvant chemotherapy (ACT), 2) lack of markers to assess ACT efficacy, 3) assessment of recurrence risk after ACT, and 4) lack of markers to guide treatment decisions for high-risk patients e.g. additional therapy or intensified surveillance. Circulating tumor DNA (ctDNA) is a promising marker with potential to mitigate the challenges. Here we used serial ctDNA measurements to assess the correlation between recurrence and ctDNA detection: postoperative, during and after ACT, and during surveillance; and to assess growth rates of metachronous metastases…

OncologyCancer Researchmedicine.medical_specialtybusiness.industryAdjuvant chemotherapyEarly RelapsePostoperative managementRecurrence riskOncologyCirculating tumor DNAInternal medicineStage III colorectal cancerAdjuvant therapyMedicinebusinessSelection (genetic algorithm)
researchProduct

LGG-16. PREDICTORS OF OUTCOME IN BRAF-V600E PEDIATRIC GLIOMAS TREATED WITH BRAF INHIBITORS: A REPORT FROM THE PLGG TASKFORCE

2019

The BRAF-V600E mutation is found in 15–20% of pediatric low grade gliomas (PLGG) and result in worse outcome and higher risk of transformation to high grade gliomas (PHGG). Although ongoing trials are assessing the role of BRAF inhibitors (BRAFi) in these children, data are still limited. We aimed to report overall response rates and predictors of outcome in childhood BRAF-V600E gliomas. We collected clinical, imaging and molecular information of patients treated with BRAFi outside trials from centers participating in the PLGG taskforce. Response was calculated by RANO criteria and follow up data were collected for all patients. Sixty-six patients were treated with BRAFi (55 PLGG and 11 PHG…

OncologyCancer Researchmedicine.medical_specialtybusiness.industryLow Grade Gliomamedicine.diseaseChemotherapy regimenBRAF V600EOncologyInternal medicineGliomaMutation (genetic algorithm)MedicineLow-Grade GliomaNeurology (clinical)businessneoplasmsNeuro-Oncology
researchProduct

Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.

2017

The purpose of this study was to investigate the role of features derived from breast dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and to incorporated clinical information to predict the molecular subtypes of breast cancer. In particular, 60 breast cancers with the following four molecular subtypes were analyzed: luminal A, luminal B, human epidermal growth factor receptor-2 (HER2)-over-expressing and basal-like. The breast region was segmented and the suspicious tumor was depicted on sequentially scanned MR images from each case. In total, 90 features were obtained, including 88 imaging features related to morphology and texture as well as dynamic features from tumor and …

OncologyCancer Treatmentlcsh:MedicineInvasive Ductal CarcinomaLogistic regression030218 nuclear medicine & medical imagingDiagnostic Radiology0302 clinical medicineMathematical and Statistical TechniquesBreast TumorsImage Processing Computer-AssistedMedicine and Health Scienceslcsh:ScienceMultidisciplinarymedicine.diagnostic_testHuman epidermal growth factorRadiology and ImagingMiddle AgedMagnetic Resonance ImagingOncology030220 oncology & carcinogenesisArea Under CurvePhysical SciencesFemaleAlgorithmsStatistics (Mathematics)Research ArticleAdultmedicine.medical_specialtyImaging TechniquesImage processingBreast NeoplasmsResearch and Analysis MethodsCarcinomasSkewness03 medical and health sciencesBreast cancerText miningDiagnostic MedicineInternal medicineImage Interpretation Computer-AssistedBreast CancermedicineBiomarkers TumorHumansStatistical MethodsDifferentiated TumorsAgedNeoplasm StagingReceiver operating characteristicbusiness.industrylcsh:RCancers and NeoplasmsMagnetic resonance imagingLuminal amedicine.diseaseImage EnhancementProbability TheoryProbability Distributionlcsh:QNeoplasm GradingbusinessMathematicsForecastingPloS one
researchProduct

KRAS/NRAS and BRAF Mutations in the 20050181 Study of Panitumumab + FOLFIRI for the 2ND-Line Treatment of Metastatic Colorectal Cancer: Updated Analy…

2014

OncologyNeuroblastoma RAS viral oncogene homologmedicine.medical_specialtyColorectal cancerbusiness.industryHematologymedicine.diseaseOncologyInternal medicineMutation (genetic algorithm)medicineCancer researchFOLFIRIPanitumumabLine (text file)businessmedicine.drugAnnals of Oncology
researchProduct